Duan Yongping
H&H International Investment
Duan Yongping Berkshire Hathaway Inc stake
total: 40
H&H International Investment BRK-B trades
- Total transactions:
- 27
- New positions:
- 1
- Added:
- 9
- Reduced:
- 17
- Held since:
- 2018 Q4
- Held for:
- 30 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Duan Yongping holds 9,147,796 Berkshire Hathaway Inc (BRK-B) shares with a market value of roughly $4.38B accounting for 21.91% of the overall portfolio. To date, the estimated cost basis is nearly $302.81 for "buy" trades and estimated average "sell" price is $327.37. H&H International Investment first purchased BRK-B in 2018 Q4, initially acquiring 950,000 shares. Since the initial investment in Berkshire Hathaway Inc (BRK-B), H&H International Investment has made 26 more transactions.
When did Duan Yongping buy Berkshire Hathaway Inc (BRK-B)?
Duan Yongping first invested in Berkshire Hathaway Inc (BRK-B) in 2018 Q4 at the reported quarter-end price of $204.18 per share.
What's the cost basis of H&H International Investment's BRK-B stake?
The estimated cost basis for Berkshire Hathaway Inc (BRK-B) stake is around $302.81 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $302.81
- Weighted AVG sell price:
- $327.37
Duan Yongping's historical trades in Berkshire Hathaway Inc
27 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
21.91%
|
9,147,796
|
$479.20
|
$4,383,623,843
|
+27.47% (+1,971,600)
|
+4.72%
|
|
2025 Q4
|
20.63%
|
7,176,196
|
$502.65
|
$3,607,114,919
|
+38.24% (+1,984,896)
|
+5.7%
|
|
2025 Q3
|
17.78%
|
5,191,300
|
$502.74
|
$2,609,874,162
|
+53.53% (+1,810,000)
|
+6.2%
|
|
2025 Q1
|
15.00%
|
3,381,300
|
$532.58
|
$1,800,812,754
|
-6.62% (-239,800)
|
-0.88%
|
|
2024 Q4
|
11.31%
|
3,621,100
|
$453.28
|
$1,641,372,208
|
-4.26% (-161,000)
|
-0.44%
|
|
2024 Q3
|
10.52%
|
3,782,100
|
$460.26
|
$1,740,749,346
|
-3.00% (-117,000)
|
-0.32%
|
|
2024 Q2
|
9.54%
|
3,899,100
|
$406.80
|
$1,586,153,880
|
-4.72% (-193,100)
|
-0.55%
|
|
2024 Q1
|
12.12%
|
4,092,200
|
$420.52
|
$1,720,851,944
|
-13.78% (-654,102)
|
-1.9%
|
|
2023 Q4
|
11.71%
|
4,746,302
|
$356.66
|
$1,692,816,071
|
-5.19% (-259,800)
|
-0.7%
|
|
2023 Q3
|
13.21%
|
5,006,102
|
$350.30
|
$1,753,637,531
|
-11.62% (-658,363)
|
-1.56%
|
|
2023 Q2
|
13.07%
|
$341.00
|
-0.39% (-22,000)
|
|||
|
2023 Q1
|
13.20%
|
$308.77
|
-9.66% (-608,000)
|
|||
|
2022 Q4
|
17.95%
|
$308.90
|
-3.00% (-194,796)
|
|||
|
2022 Q3
|
18.33%
|
$267.02
|
-4.07% (-275,200)
|
|||
|
2022 Q1
|
25.31%
|
$352.91
|
-4.11% (-289,800)
|
|||
|
2021 Q4
|
26.02%
|
$299.00
|
-5.93% (-444,400)
|
|||
|
2021 Q3
|
26.34%
|
$272.94
|
+4.90% (+350,000)
|
|||
|
2021 Q2
|
25.10%
|
$277.92
|
-7.29% (-562,515)
|
|||
|
2021 Q1
|
27.40%
|
$255.47
|
-13.80% (-1,234,000)
|
|||
|
2020 Q4
|
29.56%
|
$231.87
|
+0.85% (+75,000)
|
|||
|
2020 Q3
|
30.65%
|
$212.94
|
+4.29% (+365,100)
|
|||
|
2020 Q2
|
29.28%
|
$178.51
|
+393.79% (+6,782,661)
|
|||
|
2020 Q1
|
10.84%
|
$182.83
|
+80.06% (+765,815)
|
|||
|
2019 Q4
|
11.03%
|
$226.50
|
-20.06% (-240,000)
|
|||
|
2019 Q3
|
15.78%
|
$208.02
|
+34.45% (+306,600)
|
|||
|
2019 Q2
|
13.06%
|
$213.17
|
-6.32% (-60,000)
|
|||
|
2018 Q4
|
23.21%
|
$204.18
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.